MedPath
HSA Approval

MOXIFLOXACIN KABI SOLUTION FOR INFUSION 400MG/250ML

SIN15310P

MOXIFLOXACIN KABI SOLUTION FOR INFUSION 400MG/250ML

MOXIFLOXACIN KABI SOLUTION FOR INFUSION 400MG/250ML

July 31, 2017

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Therapeutic

Prescription Only

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Medical Information

J01MA14

moxifloxacin

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Fresenius Kabi Poland Sp. z.o.o

Active Ingredients

Moxifloxacin Hydrochloride 437.5mg/250ml eqv Moxifloxacin

400mg/250ml

Moxifloxacin
© Copyright 2025. All Rights Reserved by MedPath